<?xml version="1.0" encoding="UTF-8"?>
<p>The paper by 
 <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2019.01097" xmlns:xlink="http://www.w3.org/1999/xlink">Hong et al.</ext-link> focused on atopic dermatitis (AD), of unknown origin. KHU-ATO-JIN-D (KAJD) which is a poly-herbal mixture of extracts from six plants, known to have anti-inflammatory and antiallergic effects, was found to inhibit the development of DNCB-induced AD in BALB/c mice and several immune cell types, suggesting that KAJD might be a useful therapeutic drug for the treatment of AD (
 <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2019.01097" xmlns:xlink="http://www.w3.org/1999/xlink">Hong et al.</ext-link>).
</p>
